Antibodies against neuronal nicotinic receptor subtypes in neurological disorders

Journal of Neuroimmunology

Volumn 102, Issue 1, 2000, Pages 89-97

  Balestra, Barbara ^a   Moretti, Milena ^a   Longhi, Renato ^b   Mantegazza, Renato ^c   Clementi, Francesco ^a   Gotti, Cecilia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CNR   (Italy)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Antibodies; Epibatidine; Myasthenia gravis; Neuronal nicotinic receptor subtypes; Bungarotoxin

Indexed keywords

AUTOANTIBODY; NICOTINIC RECEPTOR; RECEPTOR ANTIBODY; RECEPTOR SUBTYPE;

ARTICLE; CELL LINE; CLINICAL TRIAL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MYASTHENIA GRAVIS; NEUROBLASTOMA CELL; NEUROLOGIC DISEASE; PRIORITY JOURNAL;

EID: 0033992081     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00145-9     Document Type: Article

References (24)

1. Asbury A.K., Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 27:1990;S21-S24.
2. Corriveau R., Romano S., Conroy W., Oliva W., Berg D. Expression of neuronal acetylcholine receptor genes in vertebrate skeletal muscle during development. J. Neurosci. 15:1995;1372-1382.
3. Gerzanich V., Peng X., Wang F., Wells G., Anand R., Fletcher S., Lindstrom J. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 48:1995;774-782.
4. Gotti C., Mantegazza R., Clementi F. New antigen for antibody detection in myasthenia gravis. Neurology. 34:1984;374-377.
5. Gotti C., Hanke W., Maury K., Moretti M., Ballivet M., Clementi F., Bertrand D. Pharmacology and biophysical properties of α7 and α7-α8 αBungarotoxin receptor subtypes immunopurified from chick optic lobe. Eur. J. Neurosci. 6:1994;1281-1291.
6. Gotti C., Briscini L., Verderio C., Oortgiesen M., Balestra B., Clementi F. Native nicotinic acetylcholine receptors in human IMR32 neuroblastoma cells: functional, immunological and pharmacological properties. Eur. J. Neurosci. 7:1995;2083-2092.
7. Gotti C., Fornasari D., Clementi F. Human neuronal nicotinic acetylcholine receptors. Progr. Neurobiol. 53:1997;199-237.
8. Gotti C., Balestra B., Moretti M., Rovati Ge., Maggi L., Rossoni G., Berti F., Villa L., Pallavicini M., Clementi F. 4-Oxystilbene compounds are selective ligands for neuronal nicotinic αBungarotoxin receptors. Br. J. Pharmacol. 124:1998;1197-1206.
9. Léna C., Changeux J.-P. Pathological mutations of nicotinic receptors and nicotine-based therapies for brain disorders. Curr. Opin. Neurobiol. 7:1997;674-682.
10. Le Novère N., Changeux J.-P. Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells. J. Mol. Evol. 40:1995;155-172.
11. Lindstrom J. Nicotinic acetylcholine receptors in health and disease. Mol. Neurobiol. 15:1997;193-222.
12. Liyange Y., Teo M., MacLennon C., Buckel A., Beeson D., Willcox N., Newsom-Davies J., Vincent A. Expression of muscle proteins in thymomas of patients with myasthenia gravis. Ann. NY Acad. Sci. 841:1998;411-413.
13. Meager A., Vincent A., Newson-Davis J., Willicox N. Spontaneous neutralising antibodies to interferon-alpha and interleukin 12 in thymoma-associated autoimmune disease. Lancet. 350:1997;1596-1597.
14. Role L. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57:1995;521-546.
15. Role L., Berg K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron. 16:1996;1077-1085.
16. Romano S., Corriveau R., Scharz R., Berg D. Expression of nicotinic receptor α7 gene in tendon and periosteum during development. J. Neurochem. 68:1997;640-647.
17. Sargent P. The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16:1993;403-443.
18. Stoica E., Enolescu E. Deficiency of sympathetic nervous system function in myasthenia. J. Auton. Nerv. Syst. 38:1992;69-76.
19. Tuckerd A., Roeltgen D., Wann P., Wertheimer S. Memory disfunction in myasthenia gravis: evidence for central cholinergic effects. Neurology. 38:1988;1173-1177.
20. Vernino S., Adamaski J., Kryzer T., Fealey R., Lennon V. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer related syndromes. Neurology. 50:1998;1806-1813.
21. Wang F., Gerzanich V., Wells G., Anand R., Peng X., Keyser K., Lindstom J. Assembly of human neuronal nicotinic receptors α5 subunits with α3, β2 and β4 subunits. J. Biol. Chem. 271:1996;17656-17665.
22. Whiting P., Cooper J., Lindstrom J. Antibodies in sera from patients with myasthenia gravis do not bind to nicotinic acetylcholine receptors from human brain. J. Neuroimm. 16:1988;205-213.
23. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.
24. Yu C., Role L. Functional contribution of the α5 subunit to neuronal nicotinic channels expressed by chick sympathetic ganglion neurones. J. Physiol. 509:1998;667-681.